0001171843-23-001684.txt : 20230314 0001171843-23-001684.hdr.sgml : 20230314 20230314164638 ACCESSION NUMBER: 0001171843-23-001684 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230310 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blanchard Cheryl R CENTRAL INDEX KEY: 0001326530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 23731692 MAIL ADDRESS: STREET 1: C/O ZIMMER, INC. STREET 2: P.O. BOX 708 CITY: WARSAW STATE: IN ZIP: 46580 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 4 1 ownership.xml X0306 4 2023-03-10 0 0000898437 Anika Therapeutics, Inc. ANIK 0001326530 Blanchard Cheryl R 32 WIGGINS AVENUE BEDFORD MA 01730 1 1 0 0 President, CEO, Director Common Stock 2023-03-10 4 M 0 30060 0 A 113791 D Common Stock 2023-03-10 4 F 0 13211 26.10 D 100580 D Common Stock 11742 I Revocable Trust Restricted Stock Unit 0.00 2023-03-10 4 M 0 30060 0 D Common Stock 30060 60119 D Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 11, 2022. Reflects an aggregate of 13,211 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2023. Reflects the closing price of ANIK common stock on March 10, 2023, the trading day immediately preceding the date on which the vesting of RSUs gave rise to tax withholding obligations. Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023. /s/ Cheryl R. Blanchard 2023-03-14